CB vs RIGL · P/E 14, rev $59.40B vs P/E 9.1, rev $179.3M
Chubb Ltd (CB) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
CB currently screens at market cap $114.26B and trailing P/E 13.7. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the CB and RIGL stock pages for the full models.
Not investment advice.